{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:24:47Z","timestamp":1787156687529,"version":"build-2736575974"},"reference-count":89,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtha.2026.06.020","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:39:25Z","timestamp":1782491965000},"page":"3116-3127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Physiological anticoagulant deficiencies: pathogenesis, diagnosis, and clinical implications"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1990-5040","authenticated-orcid":false,"given":"Katarzyna","family":"Mayger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2163-8778","authenticated-orcid":false,"given":"Christelle","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4709-0774","authenticated-orcid":false,"given":"Beverley J.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.06.020_bib1","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1182\/blood.V94.10.3413.422k24_3413_3420","article-title":"Tissue factor and factor VIIa receptor\/ligand interactions induce proinflammatory effects in macrophages","volume":"94","author":"Cunningham","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.020_bib2","first-page":"21","article-title":"Enzyme catalysis: the serine proteases","volume":"3","author":"Neitzel","year":"2010","journal-title":"Nat Educ"},{"key":"10.1016\/j.jtha.2026.06.020_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/hae.12427","article-title":"Primary haemostasis: newer insights","volume":"20","author":"Berndt","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.06.020_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2006-939550","article-title":"An overview of the structure and function of thrombin","volume":"32","author":"Davie","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib5","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1182\/blood-2005-04-1710","article-title":"Directing thrombin","volume":"106","author":"Lane","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.020_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/beha.1999.0032","article-title":"Activation markers of coagulation","volume":"12","author":"Bauer","year":"1999","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jtha.2026.06.020_bib7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nsb971","article-title":"Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins","volume":"10","author":"Huang","year":"2003","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.jtha.2026.06.020_bib8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood.V116.21.1141.1141","article-title":"Structural insights into how clotting proteins with GLA domains bind to membrane surfaces","volume":"116","author":"Davis-Harrison","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.020_bib9","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/j.1538-7836.2005.01363.x","article-title":"Molecular recognition mechanisms of thrombin","volume":"3","author":"Huntington","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib10","first-page":"81","article-title":"Endogenous anticoagulants. Top Companion","volume":"27","author":"Kubier","year":"2012","journal-title":"Anim Med"},{"key":"10.1016\/j.jtha.2026.06.020_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1538-7836.2011.04360.x","article-title":"Serpin structure, function and dysfunction","volume":"9","author":"Huntington","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/35038119","article-title":"Structure of a serpin-protease complex shows inhibition by deformation","volume":"407","author":"Huntington","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2026.06.020_bib13","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1046\/j.1538-7836.2003.00305.x","article-title":"Mechanisms of glycosaminoglycan activation of the serpins in hemostasis","volume":"1","author":"Huntington","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1055\/s-0038-1655981","article-title":"Anticoagulant properties of the vascular endothelium","volume":"77","author":"Bombeli","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib15","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1182\/blood.V97.4.1079","article-title":"Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III","volume":"97","author":"Dunzendorfer","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.020_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/jth.13899","article-title":"Associations of activated coagulation factor VII and factor VIIa-antithrombin levels with genome-wide polymorphisms and cardiovascular disease risk","volume":"16","author":"Olson","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib17","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jtha.2024.01.006","article-title":"Thrombomodulin: a multifunctional receptor modulating the endothelial quiescence","volume":"22","author":"Giri","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood-2008-01-077909","article-title":"Advances in understanding pathogenic mechanisms of thrombophilic disorders","volume":"112","author":"Dahlb\u00e4ck","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.020_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1532\/IJH97.03149","article-title":"Progress in the understanding of the protein C anticoagulant pathway","volume":"79","author":"Dahlb\u00e4ck","year":"2004","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtha.2026.06.020_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.ATV.12.2.135","article-title":"The protein C anticoagulant pathway","volume":"12","author":"Esmon","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.jtha.2026.06.020_bib21","doi-asserted-by":"crossref","first-page":"11128","DOI":"10.1016\/S0021-9258(19)68566-2","article-title":"Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation","volume":"256","author":"Walker","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2026.06.020_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102330","article-title":"Factor V variants in bleeding and thrombosis","volume":"8","author":"Mohapatra","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1160\/TH07-03-0199","article-title":"Molecular basis of protein S deficiency","volume":"98","author":"de Frutos","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/ATVBAHA.117.310588","article-title":"Anticoagulant protein S targets the factor IXa heparin-binding exosite to prevent thrombosis","volume":"38","author":"Plautz","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.06.020_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1538-7836.2009.03363.x","article-title":"Regulation of TFPI function by protein S","volume":"7","author":"Hackeng","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib26","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1182\/blood.V108.11.1714.1714","article-title":"Protein S down-regulates factor VIIIa by competing with factor IXa","volume":"108","author":"Takeyama","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.020_bib27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/gb-2006-7-5-216","article-title":"An overview of the serpin superfamily","volume":"7","author":"Law","year":"2006","journal-title":"Genome Biol"},{"key":"10.1016\/j.jtha.2026.06.020_bib28","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1182\/blood.V87.6.2301.bloodjournal8762301","article-title":"Initiation of the tissue factor pathway of coagulation in the presence of heparin: control by antithrombin III and tissue factor pathway inhibitor","volume":"87","author":"Jesty","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.020_bib29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2044.2004.03679.x","article-title":"Tissue factor and tissue factor pathway inhibitor","volume":"59","author":"Price","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jtha.2026.06.020_bib30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/jth.12897","article-title":"New insights into the biology of tissue factor pathway inhibitor","volume":"13","author":"Maroney","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib31","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood.V90.3.944","article-title":"Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice","volume":"90","author":"Huang","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.020_bib32","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/00001721-199410000-00020","article-title":"Measurement of tissue factor pathway inhibitor in normal and post-heparin plasma","volume":"5","author":"Hubbard","year":"1994","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2026.06.020_bib33","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/01.ATV.13.7.1066","article-title":"Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a)","volume":"13","author":"Lesnik","year":"1993","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.06.020_bib34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0031-1276582","article-title":"Heparin cofactor II: discovery, properties, and role in controlling vascular homeostasis","volume":"37","author":"Rau","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib35","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/jth.15647","article-title":"Alpha-2-macroglobulin in hemostasis and thrombosis: an underestimated old double-edged sword","volume":"20","author":"Lagrange","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1182\/blood-2012-03-419523","article-title":"The kunitz protease inhibitor domain of protease nexin-2 inhibits factor XIa and murine carotid artery and middle cerebral artery thrombosis","volume":"120","author":"Wu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.020_bib37","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.rmed.2011.02.002","article-title":"The discovery of \u03b11-antitrypsin and its role in health and disease","volume":"105","author":"Janciauskiene","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.jtha.2026.06.020_bib38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2141.2004.05189.x","article-title":"Mutations within the protein Z-dependent protease inhibitor gene are associated with venous thromboembolic disease: a new form of thrombophilia","volume":"127","author":"Van De Water","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.06.020_bib39","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1160\/TH09-09-0645","article-title":"A meta-analysis of potential risks of low levels of protein Z for diseases related to vascular thrombosis","volume":"103","author":"Sofi","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib40","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1182\/blood-2002-10-3188","article-title":"Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis","volume":"101","author":"Dahm","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.020_bib41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/bjh.18239","article-title":"Thrombophilia testing: a British Society for Haematology guideline","volume":"198","author":"Arachchillage","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.06.020_bib42","first-page":"1","article-title":"Inherited thrombophilia: a double-edged sword","volume":"1","author":"Middeldorp","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2026.06.020_bib43","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2165\/00003495-200767100-00005","article-title":"Hereditary and acquired antithrombin deficiency epidemiology, pathogenesis and treatment options","volume":"67","author":"Maclean","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.jtha.2026.06.020_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/(SICI)1098-1004(1996)7:1<7::AID-HUMU2>3.0.CO;2-B","article-title":"Molecular genetics of human antithrombin deficiency","volume":"7","author":"Perry","year":"1996","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jtha.2026.06.020_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jth.14648","article-title":"Recommendations for clinical laboratory testing for antithrombin deficiency; communication from the SSC of the ISTH","volume":"18","author":"Van Cott","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib46","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1172\/JCI10489","article-title":"Complete antithrombin deficiency in mice results in embryonic lethality","volume":"106","author":"Ishiguro","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2026.06.020_bib47","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/jth.13252","article-title":"Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort","volume":"14","author":"Gindele","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.thromres.2018.11.006","article-title":"The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications","volume":"173","author":"Kovac","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.06.020_bib49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.thromres.2017.10.023","article-title":"Clinical and laboratory characteristics of antithrombin deficiencies: a large cohort study from a single diagnostic center","volume":"160","author":"Gindele","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.06.020_bib50","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/17474086.2020.1804354","article-title":"Genetic risk factors for venous thromboembolism","volume":"13","author":"Z\u00f6ller","year":"2020","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jtha.2026.06.020_bib51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0037-1613762","article-title":"Thirty-three novel mutations in the protein C gene. French INSERM network on molecular abnormalities responsible for protein C and protein S","volume":"83","author":"Alhenc-Gelas","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib52","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1055\/s-0044-1786807","article-title":"Thrombophilia screening: not so straightforward","volume":"50","author":"Moore","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib53","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/jth.14667","article-title":"Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH","volume":"18","author":"Cooper","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib54","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1160\/TH11-12-0875","article-title":"Deficiencies of antithrombin, protein C and protein S\u2014practical experience in genetic analysis of a large patient cohort","volume":"108","author":"Caspers","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib55","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.5858\/arpa.2017-0403-RS","article-title":"Protein C deficiency","volume":"143","author":"Dinarvand","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtha.2026.06.020_bib56","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0038-1653730","article-title":"Prevalence of protein C deficiency in the healthy population","volume":"73","author":"Tait","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib57","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1538-7836.2004.00742.x","article-title":"Prevalence of protein S deficiency in the Japanese general population: the Suita study","volume":"2","author":"Sakata","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib58","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1046\/j.1365-2141.2001.02813.x","article-title":"A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state","volume":"113","author":"Dykes","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.06.020_bib59","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ajh.21992","article-title":"Protein S abnormalities: a diagnostic nightmare","volume":"86","author":"Marlar","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.06.020_bib60","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nsb0295-96","article-title":"What do dysfunctional serpins tell us about molecular mobility and disease?","volume":"2","author":"Stein","year":"1995","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.jtha.2026.06.020_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5152\/TurkPediatriArs.2018.2586","article-title":"Thrombosis in children: which test to whom, when and how much necessary?","volume":"53","author":"Celkan","year":"2018","journal-title":"Turk Pediatr Ars"},{"key":"10.1016\/j.jtha.2026.06.020_bib62","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bjae.2019.05.003","article-title":"Venous thromboembolism in paediatrics","volume":"19","author":"Jinks","year":"2019","journal-title":"BJA Educ"},{"key":"10.1016\/j.jtha.2026.06.020_bib63","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/jth.12372","article-title":"Developmental hemostasis: age-specific differences in the levels of hemostatic proteins","volume":"11","author":"Attard","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib64","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1182\/blood.V78.9.2299.2299","article-title":"Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children","volume":"78","author":"Mitchell","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.020_bib65","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.siny.2011.07.009","article-title":"Diagnosis and management of neonatal purpura fulminans","volume":"16","author":"Price","year":"2011","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.jtha.2026.06.020_bib66","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-2007-1002683","article-title":"Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies","volume":"16","author":"Marlar","year":"1990","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib67","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.06.020_bib68","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.jtha.2025.05.021","article-title":"Hidden antithrombin defects: time to change and improve our thrombophilia diagnostic approach","volume":"23","author":"Corral","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib69","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/jth.15109","article-title":"Recommendations for clinical laboratory testing for protein S deficiency: communication from the SSC committee plasma coagulation inhibitors of the ISTH","volume":"19","author":"Marlar","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib70","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/jth.14532","article-title":"Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH","volume":"17","author":"Moore","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib71","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1309\/AJCPVY4Z9XZMFOTH","article-title":"The superiority of anti-fxa assay over anti-fiia assay in detecting heparin-binding site antithrombin deficiency","volume":"140","author":"Kov\u00e1cs","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtha.2026.06.020_bib72","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1182\/blood-2006-08-040774","article-title":"Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis","volume":"109","author":"Corral","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.020_bib73","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1182\/blood-2003-05-1560","article-title":"Heparin-induced substrate behavior of antithrombin Cambridge II","volume":"102","author":"Mushunje","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.020_bib74","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2141.2009.08022.x","article-title":"Clinical guidelines for testing for heritable thrombophilia","volume":"149","author":"Baglin","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.06.020_bib75","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMra1700365","article-title":"Thrombophilia testing and venous thrombosis","volume":"377","author":"Connors","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.06.020_bib76","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.thromres.2019.11.008","article-title":"Diagnosis and management of congenital thrombophilia in the era of direct oral anticoagulants","volume":"185","author":"Alameddine","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.06.020_bib77","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1515\/cclm-2018-1041","article-title":"Danger of false negative (exclusion) or false positive (diagnosis) for \u2018congenital thrombophilia\u2019 in the age of anticoagulants","volume":"57","author":"Favaloro","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jtha.2026.06.020_bib78","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.thromres.2015.05.001","article-title":"Direct oral anticoagulants (DOACs) in the laboratory: 2015 review","volume":"136","author":"Adcock","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.06.020_bib79","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3390\/ijms23031821","article-title":"Inherited thrombophilia in the era of direct oral anticoagulants","volume":"23","author":"Khider","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2026.06.020_bib80","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.thromres.2018.01.047","article-title":"Simple method for removing DOACs from plasma samples","volume":"163","author":"Exner","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.06.020_bib81","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/bjh.16091","article-title":"A diagnostic solution for haemostasis laboratories for patients taking direct oral anticoagulants using DOAC-Remove","volume":"187","author":"Cox-Morton","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.06.020_bib82","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1751-553X.2011.01332.x","article-title":"Inappropriate use of protein C, protein S, and antithrombin testing for hereditary thrombophilia screening: an experience from a large university hospital","volume":"33","author":"Tientadakul","year":"2011","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2026.06.020_bib83","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/14737159.2025.2588621","article-title":"Diagnosing thrombophilia: the case for genetic or functional testing?","volume":"25","author":"Favaloro","year":"2025","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jtha.2026.06.020_bib84","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/j.jtha.2025.05.016","article-title":"Genotype vs laboratory phenotype correlation of defects in natural anticoagulants in patients with venous thromboembolism","volume":"23","author":"Van Laer","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib85","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-0038-1650289","article-title":"Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency","volume":"75","author":"Van Boven","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib86","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jtha.2025.10.032","article-title":"Survey on current practice in thrombophilia testing: from phenotype to genotype. Communication from the SSC of the ISTH","volume":"24","author":"Van Laer","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib87","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1016\/j.jtha.2025.07.044","article-title":"When genotype and phenotype disagree: rethinking thrombophilia testing in the genomic era","volume":"23","author":"Ryu","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.020_bib88","article-title":"Identification of regulatory mutations in SERPINC1 affecting vitamin D response elements associated with antithrombin deficiency","volume":"11","author":"Toderici","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2026.06.020_bib89","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/jth.13372","article-title":"Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect","volume":"14","author":"de la Morena-Barrio","year":"2016","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626004058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626004058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:30:23Z","timestamp":1787153423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626004058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":89,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1538783626004058"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.06.020","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physiological anticoagulant deficiencies: pathogenesis, diagnosis, and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}